Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLSK vs GSK✓SelectedUSD · GSKCLSK vs GSK performance historyLatest closeAs of-2.38%11/17
Stock and ETF performance explorer

CLSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-82.4%
GSK return
+102.5%
Excess return
-184.9%
Maximum drawdown
-98.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.4%-2.3%-0.1%-2.5%
7D-6.4%-3.0%-3.4%-6.5%
30D-26.8%+0.4%-27.1%-26.7%
3M-50.4%-1.2%-49.2%-50.3%
6M-53.1%+0.9%-54.0%-53.1%
YTD-39.2%+4.0%-43.2%-39.2%
1Y-42.0%+7.3%-49.3%-42.0%
3Y+56.1%+57.1%-1.0%+53.3%
5Y-66.6%+43.0%-109.6%-67.8%
10Y-82.4%+103.1%-185.4%-74.1%
All-82.4%+102.5%-184.9%-73.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling